Jan 24-26, 2023 | Next Generation Ophthalmic Drug Delivery Summit | San Francisco

Jan 24-26 | Next Generation Ophthalmic Drug Delivery Summit| San Francisco

Nanoscope President and Co-Founder Samarendra Mohanty will participate in the panel discussion:
What is the Ideal System to Test Durable Ophthalmic Therapies?  Discussing Desired Attributes for a Benchmark System
Thursday, January 26  9:15am

Nanoscope President and Co-Founder Samarendra Mohanty will be a featured speaker on the topic:
Pioneering Laser-Targeted Non-contaact Optical Delivery of Therapeutics to the Eye

  • Investigating the use of optoporation as a minimally invasive non-contact method to deliver drugs to the eye
  • Assessing the safety of non-viral optical delivery of therapeutic genes to different ophthalmic indications
  • Determining targeted delivery efficiency and efficacy outcomes of optical delivery

Thursday, January 26  1:45 pm

Conference website


Nanoscope Therapeutics, Inc.
Trinity Towers
2777 N. Stemmons Fwy.
Dallas, TX 75207
(817) 857-1186
  • Dr. Samarendra Mohanty, PhD |  Co-Founder & President

    Samarendra Mohanty (Co-Founder/President) is an inventor & serial entrepreneur with 20+ years experience in Biomedical Sciences. He is Co-Founder of several Biotechs and Biomedical device /diagnostic companies (developed & commercialized $100K+ biomedical instruments.)

    Samar obtained M.Tech in Applied Optics from the Indian Institute of Technology-Delhi and a PhD in (Bio)Physics from the Indian Institute of Sciences-Bangalore.

    His extensive Biomedical Technologies experience includes serving as Professor/Senior Scientist at the University of Texas;  University of California, Irvine; Center for Adv. Tech (India); Int. Mol. Biotech (Germany); Univ. Pavia (Italy); NUS (Singapore); and University of St. Andrews (UK). He has authored over 200 international patents and publications in leading journals including Nature and Nature Photonics.

    He is the Principal Investigator for major grants from National Eye Institute including Audacious Goal Initiative and Bioengineering Research grants. He serves on the editorial board of journals and chairs international conference on optogenetics. He is winner of 2019 Healthcare Heroes award (Fort Worth Business Press), Retinal Organoid Challenge Award, Audacious Goal Initiative Award (NIH), Finalist of Tech Titan, and NIH-Director’s Innovator Award.